Clinico‑radiological and Pathological Characteristics of Inflammatory Myofibroblastic Tumors in Children: A Retrospective Study

Abstract

Purpose: Inflammatory myofibroblastic tumors (IMTs) are rare, benign lesions most often seen in the lung of young adults but can occur in children, in various sites. They mimic, clinically and radiologically, malignant tumors – especially sarcomas and lymphomas. The aim was to review the clinical, radiological, and pathological data of children with a diagnosis of IMT referred to our department. Materials and Methods: This retrospective study was conducted at the Department of Medical and Paediatric Oncology, Regional Cancer Centre, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India from January 2014 to December 2015. Results: Among 288 pediatric tumors registered during the study, 5 (1.73%) had the diagnosis of IMTs. The main symptoms were abdominal distension and pain in 60% (three cases), breathlessness and cough in 20% (one case), and right axillary area swelling in 20% (one case). In three patients, complete surgical excision was done, whereas another patient with retroperitoneal mass had the residual disease and received chemotherapy followed by complete second surgery. In the case of mediastinal IMT, surgery was followed by local radiotherapy. At present, four patients are disease-free and one patient with mediastinal IMT has the residual progressive disease. Conclusion: On presentation, IMT can constitute a formidable challenge, from diagnosis through to treatment.

Keywords

Inflammatory myofibroblastic tumors - macrolides - pseudotumors - steroids - tyrosine kinase

Publication History

Article published online:
04 July 2021

• References

• 1 Brunn H. Two interesting benign lung tumors of contradictory histopathology. J Thorac Surg 1939;9:119-31.
• 2 Umiker WO, Iverson L. Postinflammatory tumors of the lung; report of four cases simulating xanthoma, fibroma, or plasma cell tumor. J Thorac Surg 1954;28:55-63.
• 3 Hojo H, Newton WA Jr., Hamoudi AB, Qualman SJ, Wakasa H, Suzuki S, et al. Pseudosarcomatous myofibroblastic tumor of the urinary bladder in children: A study of 11 cases with review of the literature. An Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol 1995;19:1224-36.
• 4 Kenneth A, Jonathan H, Virgil G, Liang C, Edward C, Roxann N, et al. Inflammatory pseudotumor and sarcoma of urinary bladder: Differential diagnosis and outcome in thirty-eight spindle cell neoplasms. Mod Pathol 2001;14:1043-51.
• 5 Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 1995;19:859-72.
• 6 Horn LC, Reuter S, Biesold M. Inflammatory pseudotumor of the ureter and the urinary bladder. Pathol Res Pract 1997;193:607-12.
• 7 Ro JY, el-Naggar AK, Amin MB, Sahin AA, Ordonez NG, Ayala AG. Pseudosarcomatous fibromyxoid tumor of the urinary bladder and prostate: Immunohistochemical, ultrastructural, and DNA flow cytometric analyses of nine cases. Hum Pathol 1993;24:1203-10.
• 8 Roth JA. Reactive pseudosarcomatous response in urinary bladder. Urology 1980;16:635-7.
• 9 Sonobe H, Okada Y, Sudo S, Iwata J, Ohtsuki Y. Inflammatory pseudotumor of the urinary bladder with aberrant expression of cytokeratin. Report of a case with cytologic, immunocytochemical and cytogenetic findings. Acta Cytol 1999;43:257-62.
• 10 Huang WL, Ro JY, Grignon DJ, Swanson D, Ordonez NG, Ayala AG. Postoperative spindle cell nodule of the prostate and bladder. J Urol 1990;143:824-6.
• 11 Oeconomopoulou A, de Verney Y, Kanavaki K, Stefanaki K, Pavlakis K, Salakos C. Inflammatory myofibroblastic tumor of the small intestine mimicking acute appendicitis: A case report and review of the literature. J Med Case Rep 2016;10:100.
• 12 Yang L, Li W, Zhang H. Inflammatory myofibroblastic tumor of carotid artery resulting in recurrent syncope: A case report. Head Neck 2016;38:E2461-3.
• 13 Zhang X, Miao Y, Zhou WW, Xing RG. Inflammatory myofibroblastic tumor in breast: A clinicopathologic study of 2 cases. Zhonghua Bing Li Xue Za Zhi 2016;45:260-1.
• 14 Kim JS, Hong KH, Kim JS, Song JH. Medical therapy of maxillary sinus inflammatory myofibroblastic tumors. Am J Otolaryngol 2016;37:376-8.
• 15 Halpert E, Figueroa JL, Rojas A, Ortiz CI, Chaparro D, Galindo M, et al. Inflammatory myofibroblastic tumor presenting as paraneoplastic pemphigus in a 7-year-old girl. JAAD Case Rep 2016;2:37-40.
• 16 Kapusta LR, Weiss MA, Ramsay J, Lopez-Beltran A, Srigley JR. Inflammatory myofibroblastic tumors of the kidney: A clinicopathologic and immunohistochemical study of 12 cases. Am J Surg Pathol 2003;27:658-66.
• 17 Gough J, Chakrabarti S. Inflammatory pseudotumor of the liver in a patient with chronic sclerosing cholangitis. Am J Gastroenterol 1993;88:1452-3.
• 18 Thomas RM, Jaffe ES, Zarate-Osorno A, Medeiros LJ. Inflammatory pseudotumor of the spleen. A clinicopathologic and immunophenotypic study of eight cases. Arch Pathol Lab Med 1993;117:921-6.
• 19 Newbould MJ, Kelsey A, Lendon M, Gururangan S. Inflammatory pseudotumor of the liver masquerading as a metastasis in a child treated for nephroblastoma. Med Pediatr Oncol 1992;20:172-5.
• 20 Johnson K, Notrica DM, Carpentieri D, Jaroszewski D, Henry MM. Successful treatment of recurrent pediatric inflammatory myofibroblastic tumor in a single patient with a novel chemotherapeutic regimen containing celecoxib. J Pediatr Hematol Oncol 2013;35:414-6.
• 21 Salameh M, Sultan I, Barbar M, Al Hussaini M, Jameel A, Ghandour K, et al. yor causing unexplained anemia in a toddler: A case report. J Med Case Rep 2011;5:69.
• 22 Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: Comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 2007;31:509-20.
• 23 Chan JK, Cheuk W, Shimizu M. Anaplastic lymphoma kinase expression in inflammatory pseudotumors. Am J Surg Pathol 2001;25:761-8.
• 24 Lovly CM, Gupta A, Lipson D, Otto G, Brennan T, Chung CT, et al. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Discov 2014;4:889-95.
• 25 Choe JY, Go H, Jeon YK, Yun JY, Kim YA, Kim HJ, et al. Inflammatory pseudotumor-like follicular dendritic cell sarcoma of the spleen: A report of six cases with increased IgG4-positive plasma cells. Pathol Int 2013;63:245-51.
• 26 Bosse K, Ott C, Biegner T, Fend F, Siegmann-Luz K, Wallwiener D, et al. 23-year-old female with an inflammatory myofibroblastic tumour of the breast: A case report and a review of the literature. Geburtshilfe Frauenheilkd 2014;74:167-70.
• 27 Bhagat P, Bal A, Das A, Singh N, Singh H. Pulmonary inflammatory myofibroblastic tumor and IgG4-related inflammatory pseudotumor: A diagnostic dilemma. Virchows Arch 2013;463:743-7.
• 28 Tao YL, Wang ZJ, Han JG, Wei P. Inflammatory myofibroblastic tumor successfully treated with chemotherapy and nonsteroidals: A case report. World J Gastroenterol 2012;18:7100-3.
• 29 Chavez C, Hoffman MA. Complete remission of ALK-negative plasma cell granuloma (inflammatory myofibroblastic tumor) of the lung induced by celecoxib: A case report and review of the literature. Oncol Lett 2013;5:1672-6.
• 30 Watanabe H, Uruma T, Tazaki G, Tajiri T, Kikuchi R, Itoh M, et al. Remission of ALK-negative primary pulmonary inflammatory myofibroblastic tumor on treatment with clarithromycin: A case report and review of the literature. Oncol Lett 2016;11:1757-61.
• 31 Alezra E, Delforge X, Buisson P, Gourmel A, Cordonnier C, Ricard J, et al. Complete resolution of inflammatory myofibroblastic tumor of the bladder after antibiotic therapy. Arch Pediatr 2016;23:612-5.